## **Core Concept**
The patient's presentation of an erythematous butterfly rash on her cheeks is highly suggestive of **Systemic Lupus Erythematosus (SLE)**, a chronic autoimmune disease that can affect multiple organ systems. SLE is characterized by the production of various autoantibodies. The diagnosis of SLE often involves the detection of specific antibodies.

## **Why the Correct Answer is Right**
The correct answer, **antinuclear antibodies (ANA)**, is right because ANA is considered a hallmark autoantibody for SLE. **ANA** is highly sensitive for SLE, although not specific, as it can be positive in other autoimmune diseases as well. The presence of ANA, especially with a speckled or homogeneous pattern, supports the diagnosis of SLE, particularly when correlated with clinical findings like the characteristic butterfly rash.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **Anti-dsDNA** antibodies are very specific for SLE and are among the criteria for its diagnosis, they are not the initial screening test but rather a confirmatory test. They are highly specific but not as sensitive as ANA.
- **Option B:** **Anti-Ro (SS-A)** antibodies are associated with Sjögren's syndrome and SLE, particularly with neonatal lupus and subacute cutaneous lupus. They are not the first-line antibodies to assay for suspected SLE.
- **Option D:** **Anti-La (SS-B)** antibodies are also more commonly associated with Sjögren's syndrome and are not the initial test for SLE.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that while **ANA** is sensitive for SLE, a negative ANA result essentially rules out SLE, making it a crucial initial test. However, the clinical context and further testing (like Anti-dsDNA, Anti-Sm) are necessary for confirmation.

## **Correct Answer:** B. Antinuclear Antibodies (ANA).